Humanized culture of periosteal progenitors in allogeneic serum enhances osteogenic differentiation and in vivo bone formation

Stem Cells Translational Medicine

Volumn 3, Issue 2, 2014, Pages 218-228

  Roberts, Scott J ^a,b,c   Owen, Helen C ^d   Tam, Wai Long ^a,b   Solie, Lien ^d   Van Cromphaut, Sophie J ^d   Van Den Berghe, Greet ^d   Luyten, Frank P ^a,b  

^a SKELETAL BIOLOGY AND ENGINEERING RESEARCH CENTER   (Belgium)

^b Prometheus: Division of Skeletal Tissue Engineering   (Belgium)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

Author keywords

Adult stem cells; Bone; Culture; Differentiation; Mesenchymal stem cells; Osteoblast; Tissue regeneration

Indexed keywords

ALKALINE PHOSPHATASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; STAT PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR RUNX2;

ARTICLE; BONE CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPY; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; NORMAL HUMAN; OSSIFICATION; OSTEOCYTE; PERIOSTEAL PROGENITOR; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; X RAY ANALYSIS;

ADULT STEM CELLS; BONE; CULTURE; DIFFERENTIATION; MESENCHYMAL STEM CELLS; OSTEOBLAST; TISSUE REGENERATION;

ANIMALS; BLOOD PROTEINS; BONE AND BONES; CALCIUM PHOSPHATES; CATTLE; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CULTURE MEDIA; HEALTHY VOLUNTEERS; HUMANS; OSTEOCYTES; PERIOSTEUM; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; STEM CELLS; TISSUE ENGINEERING;

EID: 84894055865     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2012-0137     Document Type: Article

References (38)

1. Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007;213:341-347.
2. Jochems CE, van der Valk JB, Stafleu FR et al. The use of fetal bovine serum: Ethical or scientific problem? Altern Lab Anim 2002;30: 219-227.
3. Erickson GA, Bolin SR, Landgraf JG. Viral contamination of fetal bovine serum used for tissue culture: Risks and concerns. Dev Biol Stand 1991;75:173-175.
4. Simonetti AB, Englert GE, Campos K et al. Nanobacteria-like particles: A threat to cell cultures. Braz J Microbiol 2007;38:153-158.
5. Horwitz EM, Gordon PL, Koo WK et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci USA 2002;99:8932-8937.
6. Sundin M, Ringdén O, Sundberg B et al. No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients. Haematologica 2007;92:1208-1215.
7. van der Valk J, Mellor D, Brands R et al. The humane collection of fetal bovine serum and possibilities for serum-free cell and tissue culture. Toxicol In Vitro 2004;18:1-12.
8. Brunner D, Frank J, Appl H et al. Serumfree cell culture: The serum-free media interactive online database. ALTEX 2010;27:53-62.
9. Hodgson J. To treat or not to treat: That is the question for serum. Nat Biotechnol 1995; 13:333-334.
10. Cifrian E, Guidry A, Marquardt WW. Role of milk fractions, serum, and divalent cations in protection of mammary epithelial cells of cows against damage by Staphylococcus aureus toxins. Am J Vet Res 1996;57:308-312.
11. Doucet C, Ernou I, Zhang Y et al. Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 2005;205:228-236.
12. Aldahmash A, Haack-Sørensen M, Al- Nbaheen M et al. Human serum is as efficient as fetal bovine serum in supporting proliferation and differentiation of human multipotent stromal (mesenchymal) stem cells in vitro and in vivo. Stem Cell Rev 2011;7:860-868.
13. Roberts SJ, Geris L, Kerckhofs G et al. The combined bone forming capacity of human periosteal derived cells and calcium phosphates. Biomaterials 2011;32:4393-4405.
14. Roberts SJ, Chen Y, Moesen M et al. Enhancement of osteogenic gene expression for the differentiation of human periosteal derived cells. Stem Cell Res (Amst) 2011;7:137-144.
15. Zhou X, Holsbeeks I, Impens S et al. Noninvasive real-time monitoring by AlamarBlue® during in vitro culture of three-dimensional tissue-engineered bone constructs. Tissue Eng Part C Methods 2013;19:720-729.
16. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-408.
17. Martin I, Mastrogiacomo M, De Leo G et al. Fluorescence microscopy imaging of bone for automated histomorphometry. Tissue Eng 2002;8:847-852.
18. Hayami T, Pickarski M, Zhuo Y et al. Characterizationofarticularcartilageandsubchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis. Bone 2006;38:234-243.
19. Chen L, Jiang W, Huang J et al. Insulin-like growth factor 2 (IGF-2) potentiates BMP-9- induced osteogenic differentiation and bone formation. J Bone Miner Res 2010;25:2447-2459.
20. De Bari C, Dell'Accio F, Vanlauwe J et al. Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum 2006;54: 1209-1221.
21. Taguchi K, Ogawa R, Migita M et al. The role of bone marrow-derived cells in bone fracture repair in a green fluorescent protein chimeric mouse model. Biochem Biophys Res Commun 2005;331:31-36.
22. Colnot C, Huang S, Helms J. Analyzing the cellular contribution of bone marrow to fracture healing using bone marrow transplantation in mice. Biochem Biophys Res Commun 2006;350:557-561.
23. Colnot C. Skeletal cell fate decisions within periosteum and bone marrow during bone regeneration. J Bone Miner Res 2009;24: 274-282.
24. Chai YC, Roberts SJ, Desmet E et al. Mechanisms of ectopic bone formation by human osteoprogenitor cells on CaP biomaterial carriers. Biomaterials 2012;33:3127-3142.
25. Chai YC, Roberts SJ, Schrooten J et al. Probing the osteoinductive effect of calcium phosphate by using an in vitro biomimetic model. Tissue Eng Part A 2011;17: 1083-1097.
26. De Bari C, Dell'Accio F, Karystinou A et al. A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells. Arthritis Rheum 2008;58:240-250.
27. Nimura A, Muneta T, Koga H et al. Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: Comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum. Arthritis Rheum 2008;58:501-510.
28. Shahdadfar A, Frønsdal K, Haug T et al. In vitro expansion of human mesenchymal stem cells: Choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. STEM CELLS 2005; 23:1357-1366.
29. Haasters F, Prall WC, Anz D et al. Morphological and immunocytochemical characteristics indicate the yield of early progenitors and represent a quality control for human mesenchymal stem cell culturing. J Anat 2009;214:759-767.
30. Liu Y, Wang L, Kikuiri T et al. Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-g and TNF-a. Nat Med 2011;17:1594-1601.
31. Croitoru-Lamoury J, Lamoury FM, Caristo Met al. Interferon-g regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO). PLoS ONE 2011;6:e14698.
32. Gao J, Folghera S, Fiorentini S et al. The influence of fetal calf serum on interferongamma induced HLA-DR expression on U937 cells. J Biol Regul Homeost Agents 1993;7: 115-120.
33. Ihle JN. STATs and MAPKs: Obligate or opportunistic partners in signaling. Bioessays 1996;18:95-98.
34. Eyckmans J, Roberts SJ, Bolander J et al. Mapping calcium phosphate activated gene networks as a strategy for targeted osteoinduction of human progenitors. Biomaterials 2013; 34:4612-4621.
35. Eyckmans J, Roberts SJ, Schrooten J et al. A clinically relevant model of osteoinduction: A process requiring calcium phosphate and BMP/Wnt signalling. J Cell Mol Med 2010;14 (6B):1845-1856.
36. Cao X. Targeting osteoclast-osteoblast communication. Nat Med 2011;17:1344-1346.
37. Janicki P, Boeuf S, Steck E et al. Prediction of in vivo bone forming potency of bone marrow-derived human mesenchymal stem cells. Eur Cell Mater 2011;21:488-507.
38. Abdallah BM, Haack-Sørensen M, Fink T et al. Inhibition of osteoblast differentiation but not adipocyte differentiation of mesenchymal stem cells by sera obtained from aged females. Bone 2006;39:181-188.